ZTS—I'll probably wait a few days before buying, which allows more time for the requisite DD on valuation.
I do think the animal-heath drug business—for both food animals and pets—is a major beneficiary of The Global Demographic Tailwind, so I will likely want to own ZTS if the valuation is not excessive.
In the meantime, if you or anyone else has an educated opinion on the valuation, please chime in!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”